Abstract
121P Health-related quality of life (HRQoL) outcomes from CheckMate 77T: Neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant NIVO in resectable NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have